Newstral
Article
The Spokesman-Review on 2016-04-25 22:30
Cancer immunotherapy finds success in Seattle study of leukemia patients - Mon, 25 Apr 2016 PST
Related news
- Seattle judge: Trump’s ban on transgender troops on hold until trial - Mon, 16 Apr 2018 PSTThe Spokesman-Review
- Seattle group sends postcards seeking help for camp cleanup - Mon, 24 Apr 2017 PSTThe Spokesman-Review
- A cure for SIDS? Seattle Children’s doctor will test his theory - Mon, 25 Apr 2016 PSTThe Spokesman-Review
- Lawsuit over sidewalks could cost Seattle millions - Mon, 03 Apr 2017 PSTThe Spokesman-Review
- Penedo racks up 10 saves to thwart Seattle Sounders - Mon, 13 Apr 2015 PSTThe Spokesman-Review
- Seattle mayor scraps proposed $275 million property-tax levy - Mon, 03 Apr 2017 PSTThe Spokesman-Review
- Sheriff, former Seattle civilian oversight director to hold policing forum Tuesday night - Mon, 11 Apr 2016 PSTThe Spokesman-Review
- Former Washington State guard Noah Williams, a Seattle native, commits to Washington - Mon, 11 Apr 2022 PSTThe Spokesman-Review
- Man who sued ex-Seattle mayor over sex abuse claims died of overdose - Mon, 23 Apr 2018 PSTThe Spokesman-Review
- Seattle Genetics pays Cambridge startup $25M to grow immunotherapy portfoliobizjournals.com
- Seattle nonprofit to start immunotherapy trials for coronavirusKING 5
- Life-saving immunotherapy trials show promise at Seattle Children's: HealthLinkrssfeeds.king5.com
- Alaskan halibut, caught by a century-old Seattle boat, provides a glimpse of Amazon’s strategy with Whole Foods - Mon, 29 Apr 2019 PSTThe Spokesman-Review
- On the air - Mon, 29 Apr 2019 PSTThe Spokesman-Review
- On the air - Mon, 15 Apr 2019 PSTThe Spokesman-Review
- Seattle researchers take big step toward immunotherapy treatment for pancreatic cancerbizjournals.com
- This Seattle immunotherapy biotech's new breast cancer vaccine sailed through phase 1 trialsbizjournals.com
- Seattle biotech Kineta lands $4M contract to develop immunotherapy for infectious diseasebizjournals.com
- Seattle researchers 'excited' by initial results of COVID-19 immunotherapy trialKING 5
- Photo: Friendship garden - Mon, 11 Apr 2016 PSTThe Spokesman-Review